CLINICAL_TRIALS
withdrawal
· 2018-05-22
Clinical Trial Update: Uterine Artery Embolization and Pelvic Floor Symptoms
Summary
A clinical trial evaluating uterine artery embolization for uterine fibroids and related pelvic floor symptoms has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Leiomyoma, Incontinence | Status: WITHDRAWN